Jump to navigation
This project will address issues around fathers sleep in families with babies, with the aim of improving mental health and family functioning.
This project will use linked administrative data to understand risk for mortality and other adverse outcomes during and after opioid agonist treatment (OAT).
Regulating the availability of alcohol is one of the most effective ways to reduce harm from alcohol consumption, and local governments have a significant role.
The World Health Organization lists alcohol as one of the three primary causes of poor health in the world.
This project will be the first to assess the types, severity, and individual and contextual correlates of harms from others’ heavy drinking in a wide range of societies with greatly varying drinking cultures and policies.
This is the PhD project of Ms Shann Hulme.
This is the PhD project of Vivienne Moxham-Hall (supervised by Professor Alison Ritter and Dr Caitlin Hughes) investigating the utility of indexes
This study will investigate the first online alcohol and substance use prevention program targeted at both students and their parents.
AOD use has a negative impact on workplaces and may result in accidents, injuries, reduced productivity, abstenteesim, poor work relationships and
NDRI researchers will be collaborating with others to update the social and economic costs of smoking in Australia.
Tapentadol is a centrally acting opioid analgesic with dual mechanisms of action, specifically µ-opioid receptor agonist and noradrenaline reuptake
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Wednesday 14 August 2019